$IMMB Immunotech Laboratories is committed to the

$IMMB Immunotech Laboratories is committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Immunotech is committed to creating drugs for the better health of mankind.

While ITV-1 is Immunotech’s flagship compound for the treatment of HIV/AIDS, other compounds in Immunotech’s pipeline are also in development for the treatment HIV/AIDS. Immunotech’s commitment to the treatment and eradication of HIV extends not only to adult HIV/AIDS patients, but also for Prenatal and Pediatric HIV, as well as the development of an HIV Vaccine.